Purpose of Review There is a large variability in response to behavioral weight loss (WL) programs. Reducing rates of obesity and diabetes may require more individuals to achieve clinically significant WL post-treatment. Given that WL within the first 1-2 months of a WL program is associated with long-term WL, it may be possible to improve treatment outcomes by identifying and providing additional intervention to those with poor initial success (i.e., "early non-responders"). We review the current literature regarding early non-response to WL programs and discuss how adaptive interventions can be leveraged as a strategy to "rescue" early non-responders. Recent Findings Preliminary findings suggest that adaptive interventions, specifically stepped care approaches, offer promise for improving outcomes among early nonresponders. Summary Future studies need to determine the optimal time point and threshold for intervening and the type of early intervention to employ. Clinicians and researchers should consider the discussed factors when making treatment decisions.
Introduction
Obesity and diabetes are comorbid conditions which are major contributors to mortality in both the USA and worldwide [1, 2] . It has been projected that from 2010 to 2030, there will be a 69% increase in the number of adults with diabetes in developing countries and a 20% increase in developed countries [3] . Given that obesity is associated with an increased risk of developing diabetes, reducing rates of obesity can serve as a primary prevention method for combating diabetes diagnoses. Behavioral weight loss (WL) programs can reduce the cumulative incidence of diabetes among those at risk for diabetes as well as lead to partial or complete remission among many individuals with diabetes [4, 5] . Thus, effective WL interventions are crucial to help slow the staggering growth rates of diabetes worldwide.
Standard behavioral WL interventions traditionally employ a variety of behavioral modification techniques to assist individuals with reducing caloric intake and increasing physical activity [6, 7] . These interventions consistently produce average weight losses of 8-10% of initial body weight [8] ; however, they are costly and often result in a large degree of variability in WL response [9, 10] . For example, individuals with type 2 diabetes who received a standard behavioral WL This article is part of the Topical Collection on Obesity intervention in the Look AHEAD trial lost on average 8.6% of initial body weight at 1 year [9] . Despite this successful rate of WL averaged across participants, only approximately two thirds of participants achieved a ≥5% WL which is considered clinically significant, which means that nearly one third of participants failed to achieve a clinically meaningful WL [9] . Given this heterogeneity in response, one strategy for improving obesity treatment outcomes and preventing diabetes is to tailor interventions so that a greater proportion of individuals achieve a clinically significant WL.
In general, behavioral WL programs provide the same treatment to all individuals, and tend to be resource intensive, as evidenced by a cost of US$1800 per person in the first year of the Diabetes Prevention Program [10] . Implementing these costly treatment components, such as in-person sessions, to those who are responding well may unnecessarily increase costs and exhaust the resources available to those struggling to lose weight [11, 12] . Previous studies indicate that WL during the first few months of treatment is significantly associated with post-treatment or longer-term WL outcomes [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . Therefore, it may be useful to adapt interventions based upon how a patient initially responds, allowing individuals to start with a less intensive and lower cost treatment, only providing additional intensive treatment to those who are non-responsive. This strategy would allow for additional intervention resources to be reserved for "early non-responders" (i.e., individuals with lower than expected WL during the first 1-2 months of treatment) and could potentially increase the proportion of individuals achieving a clinically significant WL.
The purpose of this review is to (1) summarize the existing literature regarding the association between early and longterm WL, (2) describe stepped care or adaptive interventions and discuss how they can be leveraged to improve WL outcomes for early non-responders in obesity treatment programs, (3) discuss approaches for determining the WL threshold and optimal time point for identifying and intervening upon early non-responders, and (4) discuss several "early rescue" adaptive intervention approaches and offer suggestions for future research in this area.
Early Weight Loss or Program Adherence as a Marker of Success
Over the past two decades, secondary analyses have shown that WL achieved within the first few months of a WL program is positively associated with post-treatment and longerterm WL outcomes [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] . These findings have been observed among individuals with and without diabetes as well as across various types of WL programs. For example, WL programs that have been delivered individually [17, 23, 24] , in a group-based setting, and via the Internet [20] have all found that early WL is related to post-treatment WL outcomes. Similarly, WL programs that included low-calorie or very low-calorie diets [18, 24] also demonstrate the importance of early WL for long-term WL success.
Although the evidence linking early WL with both shortand long-term WL is consistent, challenges remain in trying to define early WL response due to the variability in the criteria used across the literature. "Early non-response" is most commonly referred to as WL below a specific threshold, typically ranging between 0.5 and 3% of initial body weight during the first 1-2 months of a WL program [13, 15, 20, 22, 25] . On average, approximately one quarter to one third of participants enrolled in a WL program are classified as early non-responders, depending upon the criteria utilized [13, 15, 20] . Individuals whose WL falls below the 0.5-3% range in the first 2 months generally have lower post-treatment or longterm WL success. In fact, individuals who fail to reach these early WL thresholds are between 3 and 11 times less likely to achieve a clinically significant WL compared to individuals with greater WL initially [13-15, 21, 25] .
As illustrated in Fig. 1 , WL within the first 1 month of treatment in the Look AHEAD trial was predictive of WL at 1, 4, and 8 years [14•] . These data suggest that many individuals remain on the same weight change trajectory established early on in a WL program. However, it is unclear exactly how soon after starting a WL program a response trajectory predictive of long-term WL outcomes can be determined. "Very early WL," defined as WL within the first 1-3 weeks of treatment, is also predictive of post-treatment WL, yet the predictive power of "very early" WL is not as strong as "early" WL achieved in the first 1-2 months [21, 25] . Although the optimal time point for identifying early non-responders remains unclear, these preliminary findings suggest that WL at months 1 or 2 may be a slightly better predictor of long-term WL rather than WL achieved during the first 1-3 weeks of treatment.
In addition to early WL response, examining adherence to WL program recommendations within the first few months of a program may be another potential method for identifying individuals with a reduced likelihood of WL success. Some evidence suggests that early non-responders have poorer adherence to intervention recommendations (e.g., lower session attendance, fewer days of self-monitoring) during the first 1-2 months of an intervention [14•, 15, 20] . However, because most participants, including early non-responders, tend to have high adherence during the initial stages of a WL program, it is challenging to define early non-adherence in a clinically meaningful way, as there tends to be little variability between individuals early in a WL program [14•] . Until additional research is conducted to identify concrete adherence thresholds, weight change may be a more appropriate measure for identifying early non-responders for several reasons. First, the evidence linking early and long-term WL outcomes is stronger than the associations observed between early adherence and long-term WL. Second, similar WL thresholds for identifying early non-responders could be utilized across studies, whereas adherence metrics vary based upon the intervention components (i.e., in-person sessions vs. telephone sessions). Finally, weight is an easy measure to obtain within clinical practice or a home-based setting, whereas measuring and defining adherence can often be challenging. For example, there is not a clear way to measure adherence to dietary self-monitoring, which makes identifying an adherence threshold to define non-response even more difficult [26] .
Tailoring Treatment for Early Non-responders
Given the association between early WL response and posttreatment or long-term WL, it is important to explore strategies to assist early non-responders in achieving a clinically significant WL. Pharmacotherapy guidelines from the Food and Drug Administration suggest that if a patient does not lose ≥3% of initial body weight while taking the recommended dose of a WL drug at 12 weeks, then either the pharmacotherapy regimen be discontinued or, for certain drugs, that the treatment be continued for an additional 12 weeks at a higher dose. If after an additional 12 weeks the patient does not achieve a ≥5% WL, it is recommended that the drug be discontinued [27] . Further, current Medicare guidelines state that individuals losing <3 kg after 6 months of intensive WL treatment are required to have their readiness to change assessed prior to further treatment [28] . While these obesity treatment guidelines imply that there may not be an additional therapeutic or cost advantage of continuing with the same treatment if an individual is initially unsuccessful, data discussed above indicate that these non-responders may be able to be identified even earlier than 3 months. Thus, early in a WL program may be an opportune time to identify "highrisk" individuals and to provide additional intervention or "rescue" efforts in an attempt to jump-start WL among these initially non-responsive individuals. One method for testing the efficacy of early intervention for early non-responders is through the use of adaptive interventions.
Using Adaptive and Stepped Care Interventions to Intervene Upon Early Non-responders
Adaptive interventions have the ability to adjust the sequence of treatment over time based upon one's needs, characteristics, or response, resulting in an individualized program for each participant. Stepped care is one such approach that adapts treatment based on individual response [12] . Often, stepped care consists of starting with less costly interventions first and then providing additional, more costly, and aggressive treatment to those who do not meet a specific criterion at a predetermined time point. A stepped care intervention approach has been utilized within a number of WL trials and the findings have been mixed. However, as detailed below, these studies have varied greatly in terms of the intervention employed and criteria for early non-response. Table 1 highlights several of these stepped care studies. Study durations ranged from 12 weeks to 18 months and most had small sample sizes (n ≤ 50). Some studies used only one time point and WL threshold for identifying early nonresponders [29, 30, 31 ••], while others assessed WL at various time points and intervened if an individual fell below a specific WL criteria at any one of these time points [11, 32, 33] . Intervention modifications for early non-responders included weekly individual therapy focused on problem solving [11] or motivational interviewing [32] , group-based stimulus control lessons [30] or standard behavioral WL [29] , or a combination of individual sessions, telephone calls, and meal replacement products [31••, 33] . While discrepant findings were observed across studies, most demonstrated a favorable effect of additional intervention for early non-responders [11, 31••, 32] . For the studies in which a stepped care approach did not improve WL, early non-responders were not identified until 3 months, suggesting that this may be too late to intervene [29, 33] . This highlights the importance for determining appropriate decision points and the critical window of opportunity in which to rescue these early non-responders.
When building an adaptive intervention to treat early nonresponders in a WL program, it is necessary to determine whom to intervene upon, how to intervene, and when to intervene. This includes determining the optimal time point and threshold for defining early non-response, the type of "rescue" strategy to employ while considering the cost and burden of additional intervention, and whether to re-assess WL progressed beyond initial step of intervention).
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No Effect In order to identify who is an early non-responder, a WL threshold or criteria must be determined. When choosing this WL threshold, many factors need to be considered including the clinician, researcher, and/or patient goals, as well as the cost of the treatment being provided. For instance, the cost of providing supplemental treatment to early non-responders may need to be weighed against the number of individuals that would receive this supplemental treatment who actually need it (i.e., true positives) versus those who would receive but did not need it and would have achieved a clinically significant WL without early intervention (i.e., false positives). If the cost of the "rescue" efforts are high, choosing a WL threshold with the lowest rate of false positives may be ideal (i.e., a low percentage of individuals incorrectly identified as needing additional intervention, when they would have been able to achieve a clinically significant WL without the "rescue" efforts). However, this also means that a large number of individuals who may need supplemental intervention would not receive it (i.e., high false-negative rate). If on the other hand the cost of the supplemental intervention is low, the goal may be to maximize the number of individuals receiving supplemental treatment who need it (true positives) and minimize the number of individuals not receiving supplemental treatment, but who may have benefited from it (false negatives) [13] .
To date, studies have examined early WL thresholds ranging from 0.5 to 7%, but only a few have reported sensitivity and specificity rates [13, 17, 19, 21] . For example, one study [13] evaluated several early WL thresholds for predicting achievement of a ≥10% WL and suggested that a 3% WL threshold at month 2 minimizes false positives (i.e., only 5.9% of individuals who actually need additional intervention would not have received it if this threshold was used). This WL threshold and timing may be optimal if a high-cost intervention is provided. Conversely, if the cost of the intervention was low, a 5% WL threshold at month 2 might be considered because it maximizes the number of individuals receiving additional support when it is actually needed (74%). Investigators and clinicians should consider this potential trade-off when making treatment decisions and consult previous studies which have examined the sensitivity and specificity of different WL thresholds.
To date, only a handful of stepped care trials have been conducted and all have utilized slightly different early WL thresholds for identifying and intervening upon early nonresponders (see Table 1 ). These have included <1% WL at week 3 [11, 32] , <2.3% at week 4 [31••] , and <5% at week 12 [29, 33] . Further, several of these studies sought to identify early non-responders at several time points versus a single time point; thus, the threshold varied depending upon the time point assessed (e.g., <1% at week 3 or <2% at week 12; [11, 32] ). Therefore, it is difficult to make empirically based recommendations for choosing the appropriate threshold for intervening upon early non-responders, as too few intervention studies have examined the effectiveness of a stepped care approach and inconsistent thresholds have been utilized. Further, there is likely no single ideal threshold for identifying early non-responders-this decision will likely be dependent upon the goals of the investigator or clinician.
How to Intervene: Choosing an Appropriate Intervention for Early Non-responders
Determining how to best to intervene upon early nonresponders is crucial for improving the efficacy of adaptive interventions for obesity treatment. Many options exist for how to alter the existing intervention for non-responders, whether this includes adjusting the intensity of the intervention (e.g., providing additional in-person coaching sessions) or adding new intervention components (e.g., adding text messages or meal replacements to initial treatment). The decision of how to adapt treatment for non-responders will also be highly dependent upon the type of initial intervention delivered. For example, if the initial intervention was an Internet-based program, it may be advantageous to offer individual, face-to-face counseling as a strategy to "jump-start" WL. Conversely, if the program is an intensive face-to-face intervention delivered twice per week, it may not be advantageous to offer more contact time as a potential "rescue" strategy. Instead, altering the intervention prescription may be a better alternative. Further, early intervention components should be chosen based upon their empirical efficacy when included within standard behavioral WL trials and should address WL barriers common to non-responders. For example, food-specific and general self-regulation difficulties, not knowledge, are associated with suboptimal WL outcomes. Thus, one approach would be to examine whether strategies to improve self-regulation can effectively "rescue" early nonresponders. To date, studies which have utilized problem solving [11] , motivational interviewing [32] , and a combination of goal setting and meal planning [31••] as an early intervention for non-responders have proven to be successful (see Table 1 ); however, much more work is needed to determine the most effective approaches for early non-responders.
When to Intervene Upon Early Non-responders
In addition to determining an appropriate WL threshold and treatment modification, it is equally important to consider the optimal time point(s) for assessing early non-response. There is a fine line between choosing to intervene too early and waiting to intervene until it is too late. If participants are identified too early in treatment as needing additional support, they may feel frustrated or alienated from others in the program if they are removed from the program to receive extra support; thus, this may limit the effectiveness of the early intervention [19] . Conversely, if participants are identified too late, they may already feel discouraged or they may have already begun to disengage in the program, thereby reducing the effectiveness of the early intervention. Moreover, patients may have less time to "catch up" to those who were initially successful if supplemental treatment is provided too late in the intervention. For example, one study provided early non-responders with additional intervention support between weeks 6 and 8 and then allowed these participants to continue on with regular treatment [31••] . While this additional intervention positively altered the WL trajectory among early non-responders, 12-week weight losses were still significantly lower than initial responders, possibly because this design only allowed these individuals 4 additional weeks to "catch up" to the initial responders. Thus, when designing studies with early intervention, it is important that early non-responders are given ample time to absorb the content of the early intervention and change their behaviors, prior to evaluating the effectiveness of these rescue efforts.
Another factor to consider when determining the timing for intervening on early non-responders is whether WL response should be assessed at multiple time points. Thus far, the focus has been on choosing an early WL threshold and using this threshold to identify and intervene upon early non-responders. However, using a single WL threshold at one time point fails to provide additional intervention to individuals originally classified as initial responders, but never go on to achieve a clinically significant WL (i.e., false negatives). Generally, lower initial WL thresholds for identifying early nonresponders result in higher rates of false negatives (i.e., a higher number of individuals not receiving early intervention who need it); thus, in these instances it may be advantageous to assess WL at several time points. For example, Waring and colleagues [19] found that 16-42% of women who achieved the target WL at week 3 (>1 lb/week), were no longer achieving the targeted WL during weeks 4-8. Evaluating WL progress at week 3 and again at week 8 improved sensitivity rates significantly compared to when assessed only at 3 weeks. Given that some individuals may achieve an early WL threshold but then drop below WL standards at another time point, reassessment of WL at multiple time points may be appropriate; however, much more work in this area is needed to say definitively. As summarized in Table 1 , only a few studies have examined stepped care approaches for intervening upon early non-responders and the time point when early response was assessed varied between studies. Two of the studies waited until 12 weeks to identify and intervene upon early non-responders, and in these instances, the stepped care approach was not effective [29, 33] . However, early intervention was found to be effective when individuals received additional intervention as early as week 3 [32, 34] or week 4 [31••] . Although the data is limited, together, these findings suggest that intervening sooner rather than later, may be optimal for improving WL outcomes.
Future Directions
As highlighted above, when designing a stepped care or adaptive intervention, it is challenging to determine the optimal treatment approach, the appropriate decision points and WL thresholds, and the criteria associated with evaluating response. One way to work towards answering these critical questions is to use a Sequential Multiple Assignment Randomized Trial (SMART). A SMART is a multi-stage randomized trial that allows participants to move through different stages of treatment by evaluating progress using individually tailored decision rules [35, 36] . Based on predetermined decision rules, participants may be re-randomized at specific time points to receive varying levels of treatments, allowing for the examination of these adaptations. Over the years, SMART has gained increasing attention as many researchers and clinicians see this experimental design as an efficient way to build towards individually tailored treatment. For example, the BestFIT study by Sherwood and colleagues [37••] is the first to use SMART to compare early intervention approaches for non-responders. In this study, the researchers are examining whether suboptimal responders to the standard WL treatment can achieve a greater WL when treatment is adjusted to include either portioncontrolled meals or acceptance-based behavior treatment. Further, they are simultaneously examining whether it is optimal to provide additional intervention at 1 or 2 months. Ongoing and future trials utilizing the SMART experimental design can help inform future adaptive interventions aimed at providing the most effective and timely rescue strategies to early non-responders, thereby increasing the number of individuals achieving success within a WL program.
Conclusion
As the prevalence of type 2 diabetes is expected to rise, WL interventions must be improved so that a greater proportion of patients achieve a clinically significant WL, thereby preventing or delaying future diabetes diagnoses. Early WL is a feasible and reliable indicator of treatment success and is easy to assess within a clinic or WL program. Preliminary studies show promise for improving WL outcomes by intervening upon early non-responders in the first 1-2 months of treatment. Additional research is needed to better understand the optimal time point(s) for intervening upon early nonresponders and the type of early intervention or support that is most effective for "rescuing" these individuals. While many of these decisions are dependent upon the goals of the researcher or clinician, the SMART experimental design provides an opportunity for systematically assessing the efficacy of a variety of interventions and early intervention timing. Moreover, the use of SMART can help facilitate the use of more empirically supported decisions when designing adaptive interventions.
